samedan logo
 
 
 
spacer
home > ebr > autumn 2020 > neoantigens: ip considerations for an emerging class of cancer immunotherapy
PAY PER VIEW SERVICE

 

Dear guest!

article: Neoantigens: IP Considerations for an Emerging Class of Cancer Immunotherapy
format: Adobe Acrobat PDF file
cost: £

spacer

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
News and Press Releases

Evonik recognized as a leading contract manufacturing organization for the pharmaceutical industry for the fourth year in a row

Essen, Germany. Evonik, one of the world’s largest contract development and manufacturing organizations (CDMO) for active pharmaceutical ingredients (APIs) and advanced intermediates, has been recognized as a recipient of the 2021 CMO Leadership Awards across all six categories for the fourth year running.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement